Compare Stocks → Your $200 account credit is about to expire (From MarketBeat) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSEARCA:CWINASDAQ:FTSVNASDAQ:PTF Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCWISPDR MSCI ACWI ex-US ETF$28.400.0%$27.39$23.78▼$28.50$1.72B0.82393,809 shs283,462 shsFTSVForty Seven$95.51$95.51$5.53▼$95.51$4.60B0.41.61 million shsN/APTFInvesco Dorsey Wright Technology Momentum ETF$57.38-1.6%$54.20$39.23▼$59.11$402.23M1.2329,456 shs16,817 shsBeginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCWISPDR MSCI ACWI ex-US ETF+0.53%+0.04%+3.01%+5.18%+12.96%FTSVForty Seven0.00%0.00%0.00%0.00%0.00%PTFInvesco Dorsey Wright Technology Momentum ETF-0.26%+2.10%+6.41%+14.06%+40.96%$25,000 into $109,616 in two months? (Ad)Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCWISPDR MSCI ACWI ex-US ETFN/AN/AN/AN/AN/AN/AN/AN/AFTSVForty SevenN/AN/AN/AN/AN/AN/AN/AN/APTFInvesco Dorsey Wright Technology Momentum ETFN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCWISPDR MSCI ACWI ex-US ETF0.00N/A$26.74-5.85% DownsideFTSVForty SevenN/AN/AN/AN/APTFInvesco Dorsey Wright Technology Momentum ETF0.00N/A$78.4436.71% UpsideCurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCWISPDR MSCI ACWI ex-US ETFN/AN/AN/AN/AN/AN/AFTSVForty Seven$15.68M293.33N/AN/A$7.52 per share12.70PTFInvesco Dorsey Wright Technology Momentum ETFN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCWISPDR MSCI ACWI ex-US ETFN/AN/A10.82∞N/AN/AN/AN/AN/AFTSVForty Seven-$87.62M-$2.34N/AN/AN/AN/A-50.38%-44.35%N/APTFInvesco Dorsey Wright Technology Momentum ETFN/AN/A17.72∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCWISPDR MSCI ACWI ex-US ETF$0.762.68%N/AN/AN/AFTSVForty SevenN/AN/AN/AN/AN/APTFInvesco Dorsey Wright Technology Momentum ETF$0.030.05%N/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCWISPDR MSCI ACWI ex-US ETFN/AN/AN/AFTSVForty SevenN/A14.8114.81PTFInvesco Dorsey Wright Technology Momentum ETFN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipCWISPDR MSCI ACWI ex-US ETFN/AFTSVForty Seven71.77%PTFInvesco Dorsey Wright Technology Momentum ETFN/AInsider OwnershipCompanyInsider OwnershipCWISPDR MSCI ACWI ex-US ETFN/AFTSVForty Seven37.40%PTFInvesco Dorsey Wright Technology Momentum ETFN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCWISPDR MSCI ACWI ex-US ETFN/A60.70 millionN/ANot OptionableFTSVForty Seven5748.16 millionN/ANot OptionablePTFInvesco Dorsey Wright Technology Momentum ETFN/A7.01 millionN/AOptionableCWI, ADAM, PTF, PBLT, and FTSV HeadlinesSourceHeadlineDell Trims Workforce and Projects PC Growth Amid Revenue Challenges and VMware Changesbenzinga.com - March 26 at 9:07 AMShould You Invest in the Invesco Dorsey Wright Technology Momentum ETF (PTF)?zacks.com - March 25 at 7:20 AMInvesco Dorsey Wright Technology Momentum ETF (NASDAQ:PTF) Shares Cross Above 50 Day Moving Average of $53.60americanbankingnews.com - March 23 at 4:24 AMInvesco Dorsey Wright Technology Momentum ETF (PTF)finance.yahoo.com - March 10 at 8:45 AM5 Top-Ranked Beaten-Down ETFs to Rebound in 2024msn.com - January 5 at 9:22 AMPRN Invesco Dorsey Wright Industrials Momentum ETFseekingalpha.com - November 24 at 7:59 AMPTF ETF Stock Price Historyinvesting.com - October 29 at 1:41 PMPTF: Technology Dashboard For Octobermsn.com - October 18 at 10:21 AMInvesco DWA Consumer Cyclicals Momentum ETF declares quarterly distribution of $0.0943msn.com - September 19 at 2:56 PM5 Beaten-Down Tech ETFs to Buymsn.com - August 8 at 4:13 PMInvesco DWA Financial Momentum ETFwsj.com - May 18 at 8:48 AMInvesco Dynamic Leisure and Entertainment ETF declares quarterly distribution of $0.0293msn.com - December 23 at 7:41 AMThe Implied Analyst 12-Month Target For PTFnasdaq.com - July 19 at 6:22 PMThese 3 Equal-Weight Sector ETFs Saw the Greatest Inflows in Junenasdaq.com - July 7 at 6:04 PMSPY, PFI: Big ETF Outflowsnasdaq.com - June 13 at 2:50 PMTransamerica Financial Advisors, Inc. Buys Invesco DWA Technology Momentum ETF, Invesco DWA ...gurufocus.com - February 17 at 3:06 PM5 Top-Ranked Tech ETFs to Buy at Bargain Pricefinance.yahoo.com - February 9 at 12:27 PMBest Growth ETFs for Q1 2022finance.yahoo.com - November 16 at 12:35 PMBest Growth ETFs for Q4 2021finance.yahoo.com - August 18 at 3:29 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsSPDR MSCI ACWI ex-US ETFNYSEARCA:CWISPDR MSCI ACWI ex-US ETF (the Fund) seeks to closely match the returns and characteristics of the total return performance of the MSCI ACWI ex USA Index (the Index). The Index is a float-adjusted market capitalization index that is designed to measure the combined equity market performance of developed and emerging market countries excluding the United States. The Fund's investment advisor is SSgA Funds Management, Inc.Forty SevenNASDAQ:FTSVForty Seven Inc., a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibody against CD47 that is in Phase 1b/2 clinical trials used for the treatment of cancer; FSI-189, an antibody that binds to SIRPa; and FSI-174, an anti-cKIT antibody. Forty Seven Inc. has a collaboration agreement with Genentech to include third clinical trial in non-Hodgkin's lymphoma. The company was formerly known as CD47 Sciences, Inc. Forty Seven Inc. was incorporated in 2014 and is headquartered in Menlo Park, California.Invesco Dorsey Wright Technology Momentum ETFNASDAQ:PTFPowerShares Dynamic Technology Sector Portfolio (the Fund) seeks investment results that correspond generally to the price and yield of the Dynamic Technology Sector Intellidex Index (the Index). The Index consists of stocks of the United States technology companies. These are companies that are principally engaged in the business of providing technology-related products and services, including computer hardware and software, Internet, electronics and semiconductors, and communication technologies. The Fund will invest at least 80% of its total assets in common stocks of technology companies. The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. The Find invests in various sectors, such as computers, electronics, software, semiconductors, telecommunications and commercial services. The Fund's investment adviser is Invesco PowerShares Capital Management LLC. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.